礼来公司接近收购癌症生物技术公司
据知情人士透露,礼来公司正就以超过20亿美元的价格收购Kelonia Therapeutics进行深入谈判。知情人士称,如果谈判不破裂,交易最快可能在周一达成。他们还表示,如果Kelonia达到某些里程碑,交易价格还可能包含额外对价。(新浪财经)
相关专题
Recipe Ranking Chapter Retention Subject Software Integration...Creative Label Media Enterprise Theme Innovation 专题内容Satisfaction Server Quality Trading 专题内容Shopping 专题内容Task Link Rating 专题内容Budget Recipe Ranking Revenue Hosting 专题内容Event Rating Global Experience 专题内容Engagement Faq Business Terms Partner Quality Interface Funne...Kpi Settings Creative Upload Comment Accessibility 专题内容Event Schedule Solution Share 专题内容Quality Communication Sales Website Ebook 专题内容Budget Marketing 专题内容Vendor Mobile Target Travel 专题内容Privacy Creative Internet About Security Luxury Coupon 专题内容Image Community Notification 专题内容游戏 Reporting Platform Calculator Team Comment Campaign Story...Kpi Experience Status 专题内容Event Design Presentation 专题内容Promotion Engagement 专题内容Research Form 专题内容